Cereno presents promising preclinical CS014 data as accepted at ESC 2022 congress
29 Aug 2022Event
Promising preclinical CS014 data as accepted at ESC 2022 congress
Dr. Michael Holinstat, Ass. Prof. at University of Michigan Medical School; and Director Translation Research, Cereno, presents the abstract 'CS014 – A Novel HDAC Inhibitor Regulating Platelet Activity, Fbrinolysis and Clot Stability for Prevention of Thrombosis Without Increased Risk of Bleeding' accepted at the ESC congress, held in August 26-29, 2022.